Key stats
About VanEck Pharmaceutical ETF
Home page
Inception date
Dec 20, 2011
Structure
Open-Ended Fund
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Van Eck Associates Corp.
Distributor
Van Eck Securities Corp.
PPH provides exposure to the largest, US-listed multinational pharmaceutical giants in the world. The fund holds just 25 securities, including big weights in household names. Like the underlying pharmaceutical market, PPH is top heavy and has to reweight its big holdings to accommodate RIC diversification requirements, capping a single issuer to 20%. Still, it captures the space well, even after excluding Asia entirely. Overall, PPH is a great option for investors seeking exposure to big, multinational pharma companies. The index is reviewed on a semi-annual basis.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Distribution Services
Stocks100.00%
Health Technology89.18%
Distribution Services10.82%
Bonds, Cash & Other−0.00%
Cash−0.00%
Stock breakdown by region
North America57.51%
Europe32.91%
Middle East4.94%
Asia4.64%
Latin America0.00%
Africa0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
PPH invests in stocks. The fund's major sectors are Health Technology, with 89.18% stocks, and Distribution Services, with 10.82% of the basket. The assets are mostly located in the North America region.
PPH top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 10.95% and 6.53% of the portfolio correspondingly.
PPH last dividends amounted to 0.52 USD. The quarter before, the issuer paid 0.41 USD in dividends, which shows a 21.64% increase.
PPH assets under management is 628.15 M USD. It's fallen 9.11% over the last month.
PPH fund flows account for 91.24 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, PPH pays dividends to its holders with the dividend yield of 1.97%. The last dividend (Apr 4, 2025) amounted to 0.52 USD. The dividends are paid quarterly.
PPH shares are issued by Van Eck Associates Corp. under the brand VanEck. The ETF was launched on Dec 20, 2011, and its management style is Passive.
PPH expense ratio is 0.36% meaning you'd have to pay 0.36% of your investment to help manage the fund.
PPH follows the MVIS US Listed Pharmaceutical 25. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
PPH invests in stocks.
PPH price has risen by 1.48% over the last month, and its yearly performance shows a −5.18% decrease. See more dynamics on PPH price chart.
NAV returns, another gauge of an ETF dynamics, showed a −4.82% decrease in three-month performance and has decreased by −3.08% in a year.
NAV returns, another gauge of an ETF dynamics, showed a −4.82% decrease in three-month performance and has decreased by −3.08% in a year.
PPH trades at a premium (0.00%) meaning the ETF is trading at a higher price than the calculated NAV.